News Overview

Execution of the projects is scheduled to begin in December 2025 and continue through March 2026.

The financing will be directed toward housing, land acquisition, and infrastructure projects.

Kenox, a contract drug maker with a focus on inhaled and nasal products, will handle formulation and development, while Strides brings in manufacturing scale and market access.

The company’s current order book stands at about ₹1,335 crore, with demand coming from marquee clients across the oil & gas, power, chemicals, and process industries.

On Sept 08, 2025, the Indian shares ended marginally higher on Monday

Here are some of the stocks that may see significant price movement today: Infosys, Brigade Enterprises, Strides Pharma, etc.

A quick look at 6 key global and domestic signals over the last one week

After a sharp fall in the previous week, markets recovered as India put up a good diplomatic show at the SCO in Tianjin

These next-generation modules offer stronger bifaciality of up to 80%, better performance in high temperatures, and very low annual degradation.

Vedanta surpassed Adani Group with a net present value of bid at ₹12,505 Crore in an auction carried out by lenders to find buyers for JAL.